about
Activity of novel inhibitors of Staphylococcus aureus biofilms.CDr10b inhibits the expression of cyclooxygenase-2 and inducible nitric oxide synthase induced by lipopolysaccharide.The effectiveness of anti-biofilm and anti-virulence properties of dihydrocelastrol and dihydrocelastryl diacetate in fighting against methicillin-resistant Staphylococcus aureus.A rapid nuclear staining test using cationic dyes contributes to efficient STR analysis of telogen hair roots.Microbiota Composition and Pulmonary Surfactant Protein Expression as Markers of Death by Drowning.The first report of NDM-5-producing uropathogenic Escherichia coli isolates in South Korea.Inhibition of homodimerization of toll-like receptor 4 by 4-oxo-4-(2-oxo-oxazolidin-3-yl)-but-2-enoic acid ethyl ester.Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia.Antimicrobial and antibiofilm activities of Clostridium butyricum supernatant against Acinetobacter baumanniiEfficacy of zerumbone against dual-species biofilms of Candida albicans and Staphylococcus aureusAntibiofilm and antibacterial activities of repurposing auranofin against Bacteroides fragilisPotential forensic application of receptor for advanced glycation end products (RAGE) and aquaporin 5 (AQP5) as novel biomarkers for diagnosis of drowningRepurposing auranofin to combat uropathogenic Escherichia coli biofilmsEffects of fingerprint development reagents on subsequent DNA analysisZerumbone inhibits Candida albicans biofilm formation and hyphal growthAnti-biofilm and antimicrobial effects of zerumbone against Bacteroides fragilisPotential Forensic Application of Receptor for Advanced Glycation End Products (RAGE) as a Novel Biomarker for Estimating Postmortem Interval
P50
Q36198445-C289B8B4-5D49-45FD-8856-23144C8CDA99Q38958996-DCBD6431-FE7F-4624-995F-46B1CE955465Q40219342-88EC78BA-1E74-4CE1-8FA6-5BF9BC3DFF65Q48285949-B2F41D70-5040-42D7-A455-DEEB7EA54253Q51185004-A8B7D302-191D-4CB2-BD4E-3007695393A6Q53164359-E51877E1-18CD-4BDA-AD67-91D16AAB79E7Q53455127-387D15BF-4597-4508-9F1D-EE23148941E3Q53688076-3C2700B9-867A-476C-9CD7-472366321934Q89533363-5AC32E21-BA65-4AFD-85F2-2700839B4D5EQ90484462-EF87D34D-9441-4418-A42F-4829AC401EB3Q91199489-BF76C045-C143-457B-97CC-687965EA0C9EQ91200851-9FE4CE90-3019-412B-BC91-EC9B8E138465Q92012123-D2852A64-C60C-4E5E-A792-4035119155B3Q92151275-2A5A2640-1FC7-45D8-A1BA-4BCDE1BACB2BQ92488796-655B8896-74CA-4DA4-A7BA-314C24FD792AQ92890879-69544199-2C1E-4C88-8BE0-DC62E46E01F1Q93128403-A645B49F-EA4E-4E7E-8525-F074F0418FD2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yong-Bin Eom
@ast
Yong-Bin Eom
@en
Yong-Bin Eom
@es
Yong-Bin Eom
@nl
type
label
Yong-Bin Eom
@ast
Yong-Bin Eom
@en
Yong-Bin Eom
@es
Yong-Bin Eom
@nl
prefLabel
Yong-Bin Eom
@ast
Yong-Bin Eom
@en
Yong-Bin Eom
@es
Yong-Bin Eom
@nl
P106
P31
P496
0000-0002-1569-7248